Targeting the NRF2 pathway: A promising approach for corneal endothelial dysfunction.

Curr Opin Pharmacol

Kuria Therapeutics, Inc, 6834 Cantrell Road, Suite 1651, Little Rock, AR 72207, USA. Electronic address:

Published: February 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Maintaining corneal endothelial function is required for vision, and corneal endothelial dysfunction is a major cause of visual deficits and blindness worldwide. To date there has been a dearth of innovation for therapeutics targeting the corneal endothelium. However, recent advances in understanding the role of oxidative stress and mitochondrial dysfunction have revealed potential avenues for the development of new therapies. This review summarizes recent developments in elucidating the role of the NRF2 pathway in corneal endothelial health and disease, focusing specifically on Fuchs' endothelial corneal dystrophy and the loss of corneal endothelial cells associated with cataract surgery. The pro-mitochondrial and antioxidant phenotype elicited by NRF2 activation offers a promising opportunity for new therapeutics for the diseased corneal endothelium.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coph.2023.102429DOI Listing

Publication Analysis

Top Keywords

corneal endothelial
20
nrf2 pathway
8
corneal
8
endothelial dysfunction
8
corneal endothelium
8
endothelial
6
targeting nrf2
4
pathway promising
4
promising approach
4
approach corneal
4

Similar Publications

Abtract: PURPOSE: To evaluate the correlation between corneal backscatter and visual function in patients with Fuchs endothelial corneal dystrophy (FECD).

Study Design: Prospective case series.

Methods: This study included 53 eyes from 38 patients with FECD.

View Article and Find Full Text PDF

Purpose: To evaluate whether primary graft failure (PGF) rates and endothelial cell loss (ECL) differ between surgeon-trephined/loaded and eye bank-preloaded Descemet stripping automated endothelial keratoplasty (DSAEK) grafts.

Setting: Tertiary care academic center.

Design: Retrospective case series and ex vivo laboratory study.

View Article and Find Full Text PDF

To summarize the evidence examining the outcomes of Descemet membrane endothelial keratoplasty (DMEK) using eye bank pre-stripped versus surgeon prepared grafts. Systematic review and meta-analysis. This study was conducted following the preferred reporting items for systematic reviews and meta-analyses consensus statement (PROSPERO ID: CRD42023457120).

View Article and Find Full Text PDF

Objective: To evaluate the therapeutic efficacy and inflammatory modulatory effects of combined 0.01% atropine eye drops and orthokeratology (OK) lenses in controlling myopia progression among adolescent patients.

Methods: This retrospective study analyzed clinical data from 90 adolescent patients (90 eyes) with myopia treated from April 2021 to June 2023.

View Article and Find Full Text PDF